PharmatrophiX PharmatrophiX is a company developing small molecule drugs for
neurodegenerative and other diseases. | ![]() ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. | ![]() Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. | Neurim Pharmaceuticals Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders. | |
Founding Date | Founding Date 2005 | Founding Date 1993 | Founding Date 2013 | Founding Date 1991 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations HQ | Locations San Diego, US HQ Princeton, US | Locations San Francisco, US HQ | Locations Tel Aviv-Yafo, IL HQ Zug, CH |
Employees | Employees N/A | Employees 513 | Employees 2382% decrease | Employees 20 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.4 b | Valuation ($) 495.3 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) $21m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income $391m (FY, 2025) | Net income ($142.9m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 770.8m | Total funding raised $ 194.5m | Total funding raised N/A |

ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View company
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View companyNeurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders.
View company